FASCINATION ABOUT DO-264

quinupristin/dalfopristin will enhance the amount or impact of lemborexant by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Steer clear of or Use Alternate Drug. Prevent coadministration of lemborexant with average or potent CYP3A inhibitors.This medication could result in diarrhea, and in some cases it might be significant. It could ari